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Fighting the flu: 
Devising a novel approach to address patient 
concerns with the seasonal influenza vaccine
Theodore Cisu | MS-III | November 2016
University of  Vermont College of  Medicine
UVMMC - South Burlington Family Medicine
Problem Identification
• The seasonal flu vaccine, or “flu shot” has an overall efficacy of  60% in health adults, 
according to a 2014 meta-analysis of  inactivated flu vaccine studies1. It is associated with 
significant reductions in laboratory-confirmed influenza illness, hospitalization for influenza 
and pneumonia, and death due to influenza or its complications2. 
• There are even greater reductions in morbidity and mortality in patients >65 years old and 
those at risk, particularly pregnant women and immunocompromised patients3.
• In 2015-2016, flu vaccination rates in adults across the United States ranged from 33% 
(Alaska) to 56% (Iowa), with 49% in Vermont4.
• In Vermont, vaccination rates increase with age (65% immunization rate in those >65), 
higher levels of  education (52% in college graduates), and socioeconomic status (50% in 
households earning >$75,000/year) according to 2014 data5.
Public Health Cost
• The annual health cost of  annual influenza epidemics averages $10.4 billion 
in direct medical costs.
• This accounts for 3.1 million hospitalized days and 31.4 million outpatient 
visits6.
• In Vermont, it is estimated that between 2008 and 2014, 4.8% of  the 
population received medical attention for influenza-related illness, accounting 
for annual productivity costs of  $8,938,0007.
Community Perspective
• Robert Luebbers, M.D., Physician at 
South Burlington Family Medicine
• “I have noticed that there is a need 
for more information I can give to 
patients regarding concerns with the 
flu shot. I hear the same sorts of  
concerns ever year around this time 
[November] as I recommend patients 
getting vaccinated.” 
• “I am interested in learning more 
about why patients believe the flu 
shot is any different from other 
immunizations, such as the TDaP or 
pneumonia vaccine.”
• Jan Carney, M.D., Professor of  Medicine at 
UVM College of  Medicine; Former Commissioner 
of  the Vermont Department of  Health
• “There is ample evidence supporting the flu shot 
on the VT Department of  Health and CDC 
websites, but I recognize that patients may not 
access these resources regularly.”
• “Patients don’t spend most of  their life in a 
doctor’s office. We need to find ways to reach 
patients outside of  the office - putting up flu 
shot posters in pharmacies and supermarkets, or 
playing a video clip on flu shot safety in the 




• Ten of  the most frequently-discussed questions and 
concerns as taken from anecdotal experience with patients 
during family medicine clerkship, as well as popular online 
blogs and forums when inputting the keywords “safety of  
flu shot” as an online search query.
• Responses are paraphrased from online materials available 
for health care professionals, such as UpToDate, as well as 
publicly-available resources from the Centers for Disease 
Control (CDC).
• All material herein is intentionally written at the 8th grade 
reading level.
• As the VT Department of  Health and most family 
medicine practices already have pamphlets on the flu itself, 
this material is specifically targeted to those who are 
curious or skeptical about the safety of  the flu vaccine.
Intervention Method: Pamphlet (cont…)
• Front Cover:
• Title: “Is the flu shot safe?”
• Back Cover:
• Contact information for 2-1-1 and 
patient’s physician.
• Center page:
• Specific content detailing where the 
content is sourced (physicians, CDC), as 
well as links to reliable online resources 
specifically for the inquisitive patient.
Response
• Providers were given copies of  the pamphlet to review and it was positively received, with a 
specific response that it fills an unmet need in the clinic, especially around October-January when 
flu shots are administered. 
• The pamphlet can be given either at the front desk upon check-in, or by the nurse rooming the 
patient upon detecting no prior flu immunization that year. Providers themselves can briefly go 
over the content with patients who remain skeptical during their visit or, at the very least, can give 
patients a copy to bring home with them.
• Electronic copies of  the handout were provided to healthcare providers and staff  for future use 
and distribution.
• The generic nature of  the pamphlet – i.e. not specific to the South Burlington Family Practice –
allows for distribution to other family medicine clinics within the UVM network and possibly to 
other outpatient clinics in Vermont. 
Effectiveness and Limitations of  Pamphlet
• Evaluating effectiveness:
• A 5- or 10-question survey can be given to every patient at the South Burlington Family Practice who is given a pamphlet to determine if  it 
appropriately addresses their specific concerns about the flu shot.
• Further evaluation with a satisfaction rating would be helpful in analyzing if  “they are more likely” or “less likely” to get a flu shot during that visit 
or a future visit based on getting the pamphlet.
• Will submit pamphlet to NCQA for formal medical verification of  content, allowing further distribution and updated content on a semi-regular 
basis.
• Limitations:
• This pamphlet was made under the assumption that other materials exist that adequately discuss the role of  the influenza vaccine as part of  a 
patient’s comprehensive care, as well as a discussion regarding who is most likely to benefit (and for whom it is contraindicated) from getting the 
shot.
• Does not address the various sub-types of  flu shots that exist – trivalent vs. quadrivalent and injection vs intranasal.
• There was space enough for merely 10 questions. As such, there is a good chance that the patient has questions not explicitly discussed in the 
pamphlet. There are website links that the patient can navigate for further investigation, however.
Recommendations for future projects
• Evaluating the effectiveness of  the pamphlet in a random sampling of  50 patients, with specific questions 
addressing patient satisfaction of  the material, likeliness to vaccinate after reading, and 
• A qualitative study characterizing the sources of  health information that patients find online regarding the 
“safety of  flu vaccines”
• A qualitative survey given to a large sample of  patients investigating in what ways they perceive the influenza 
vaccine is different from other ‘required’ immunizations, such as Tdap and pneumococcal vaccines.
• Formal integration of  pamphlet content into electronic health record to permit physicians to tack it on to 
visit summary information that patients take home.
• Creation of  a social media campaign and several print posters to place in local pharmacies, supermarkets, and 
wholesale clubs. Each campaign or poster would include one “Did you know?” fact de-bunking a popular 
misconception about the flu shot, as taken from the pamphlet content.
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